Category
2 articles tagged Regulatory Policy.
Analysis of supply chain vulnerabilities from the Hormuz blockade, regulatory barriers in Germany's energy transition, and the structural risks of retail prediction markets. Strategic frameworks for navigating inflation and market manipulation.
China has rapidly surpassed the US in clinical trial volume and novel drug approvals through targeted regulatory reforms. This analysis examines how streamlined ethics approvals, volume-based pricing negotiations, and larger trial enrollments are reshaping global biotech competition. US stakeholders must adapt regulatory frameworks and pricing strategies to maintain innovation leadership.
